Nuveen Asset Management, LLC Chroma Dex Corp. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 66,114 shares of CDXC stock, worth $251,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,114

Holding current value

$251,233

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.44 - $4.32 $161,318 - $285,612	66,114 New	66,114 $180,000
Q2 2022 Aug 15, 2022	SELL	$1.59 - $2.7 $1.21 Million - $2.06 Million	-762,027 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $36,240 - $70,328	-17,941 Reduced 2.3%	762,027 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$3.74 - $6.7 $7,614 - $13,641	-2,036 Reduced 0.26%	779,968 $3.13 Million
Q3 2021 Nov 12, 2021	BUY	$6.05 - $10.41 $2.53 Million - $4.35 Million	418,085 Added 114.88%	782,004 $5.3 Million
Q2 2021 Aug 16, 2021	BUY	$6.66 - $10.92 $1.38 Million - $2.26 Million	207,036 Added 131.97%	363,919 $3.59 Million
Q1 2021 May 17, 2021	BUY	$4.59 - $18.74 $69,465 - $283,611	15,134 Added 10.68%	156,883 $1.47 Million
Q4 2020 Feb 16, 2021	BUY	$3.93 - $5.5 $8,457 - $11,836	2,152 Added 1.54%	141,749 $681,000
Q3 2020 Nov 16, 2020	BUY	$4.01 - $5.56 $3,003 - $4,164	749 Added 0.54%	139,597 $560,000
Q2 2020 Aug 14, 2020	BUY	$3.0 - $5.52 $89,547 - $164,766	29,849 Added 27.38%	138,848 $637,000
Q1 2020 May 14, 2020	SELL	$2.54 - $4.75 $243 - $456	-96 Reduced 0.09%	108,999 $355,000
Q4 2019 Feb 14, 2020	SELL	$2.83 - $4.61 $5,546 - $9,035	-1,960 Reduced 1.76%	109,095 $470,000
Q3 2019 Nov 14, 2019	BUY	$3.83 - $4.72 $46,982 - $57,900	12,267 Added 12.42%	111,055 $437,000
Q2 2019 Aug 15, 2019	BUY	$3.71 - $4.83 $366,503 - $477,146	98,788 New	98,788 $460,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

16.4M

Call Options Held

91.7K

Put Options Held

18.9K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $260M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Chroma Dex Corp. Transaction History